Juergen K. Willmann, M.D.

Publication Details

• Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.

  Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J, Gambhir SS. Radiology. 2008; 248 (3): 936-44

  To develop and validate a dual-targeted ultrasonographic (US) imaging agent with microbubbles (MBs) that attaches to both vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) and alpha(v)beta(3) integrin and to compare the US imaging signal obtained from dual-targeted MBs (MB(D)) with that from single-targeted MBs (MB(S)) in a murine model of tumor angiogenesis.

  PubMedID: 18710985